Professor, Medicine, UCSF School of Medicine
Internal Medicine
Dr. Steven G. Deeks, MD
|
|
Give Review
Steven Deeks works in the field of Internal Medicine. He studied medicine at University of California San Francisco School of Medicine. University of California San Francisco School of Medicine is a top medical college. University of California San Francisco School of Medicine has a rank of 3 in research and a 3 in primary care He received 1 awards: "Elected Member". Steven Deeks is a published doctor as well. He has 101 publications published. The latest was: Do Biomarkers Of Inflammation, Monocyte Activation And Altered Coagulation Explain Excess Mortality Between HIV Infected and Uninfected People?
Publications
- Immunologic profiles distinguish aviremic HIV-infected adults.
- Do Biomarkers Of Inflammation, Monocyte Activation And Altered Coagulation Explain Excess Mortality Between HIV Infected and Uninfected People?
- Virome analysis of antiretroviral-treated HIV patients shows no correlation between T-cell activation and anelloviruses levels.
- Select host restriction factors are associated with HIV persistence during antiretroviral therapy.
- Viremic control and viral coreceptor usage in two HIV-1-infected persons homozygous for CCR5 Î32.
- Broad CTL response is required to clear latent HIV-1 due to dominance of escape mutations.
- Gut epithelial barrier and systemic inflammation during chronic HIV infection.
- Soluble Markers of Inflammation and Coagulation but Not T-Cell Activation Predict Non-AIDS-Defining Morbid Events During Suppressive Antiretroviral Treatment.
- The CD8+ memory stem T cell (TSCM) subset is associated with improved prognosis in chronic HIV-1 infection.
- Limited HIV Infection of Central Memory and Stem Cell Memory CD4+ T Cells Is Associated with Lack of Progression in Viremic Individuals.
- Cutting Edge: An Antibody Recognizing Ancestral Endogenous Virus Glycoproteins Mediates Antibody-Dependent Cellular Cytotoxicity on HIV-1-Infected Cells.
- Antiretroviral therapy: stubborn limitations persist.
- Immunologic strategies for HIV-1 remission and eradication.
- Delayed switch of antiretroviral therapy after virologic failure associated with elevated mortality among HIV-infected adults in Africa.
- Exogenous and endogenous hyaluronic acid reduces HIV infection of CD4(+) T cells.
- Decreased HIV-1 Transcription in CCR5 Delta-32 Heterozygotes On Suppressive Antiretroviral Therapy.
- A chronic kidney disease risk score to determine tenofovir safety in a prospective cohort of HIV-positive male veterans.
- HIV-Infected Individuals with Low CD4/CD8 Ratio despite Effective Antiretroviral Therapy Exhibit Altered T Cell Subsets, Heightened CD8+ T Cell Activation, and Increas...
- A closer look at hepatitis C clearance in HIV controllers: a response.
- Sevelamer Does Not Decrease Lipopolysaccharide or Soluble CD14 But Does Decrease Soluble Tissue Factor, LDL, and Oxidized LDL Levels in Untreated HIV Infection.
- Programmed death 1 expression on CD4+ and CD8+ T cells in treated and untreated HIV disease.
- Gut Epithelial Barrier Dysfunction and Innate Immune Activation Predict Mortality in Treated HIV Infection.
- Reduction of HIV Persistence Following Transplantation in HIV-Infected Kidney Transplant Recipients.
- Lymphoma Immune Reconstitution Inflammatory Syndrome in the Center for AIDS Research Network of Integrated Clinical Systems Cohort.
- Galectin-9 is Rapidly Released during Acute HIV-1 Infection and Remains Sustained at High Levels Despite Viral Suppression Even In Elite Controllers.
- LILRB2 Interaction with HLA Class I Correlates with Control of HIV-1 Infection.
- Increased levels of asymmetric dimethylarginine are associated with pulmonary arterial hypertension in HIV infection.
- The Kynurenine Pathway of Tryptophan Catabolism, CD4+ T Cell Recovery and Mortality in HIV-infected Ugandans Initiating ART.
- Low Proportions of CD28- CD8+ T cells Expressing CD57 Can Be Reversed by Early ART Initiation and Predict Mortality in Treated HIV Infection.
- Composition and Function of T Cell Subpopulations Are Slow to Change Despite Effective Antiretroviral Treatment of HIV Disease.
- A comparison of methods for measuring rectal HIV levels suggests that HIV DNA resides in cells other than CD4+T cells, including myeloid cells.
- A Pilot Study Assessing the Safety and Latency Reversing Activity of Disulfiram in HIV-1-Infected Adults on Antiretroviral Therapy.
- HIV: Antibodies advance the search for a cure.
- Discordance between peripheral and colonic markers of inflammation during suppressive ART.
- Prospective Antiretroviral Treatment of Asymptomatic, HIV-1 Infected Controllers.
- Effects of interferon-α treatment on anti-HIV-1 intrinsic immunity in vivo.
- The end of AIDS: HIV infection as a chronic disease.
- Systemic effects of inflammation on health during chronic HIV infection.
- Response: maraviroc intensification and microbial translocation.
- Comparison of HIV DNA and RNA in gut-associated lymphoid tissue of HIV-infected controllers and noncontrollers.
- The impact of age on the prognostic capacity of CD8+ T-cell activation during suppressive antiretroviral therapy.
- The Distribution of HIV DNA and RNA in Cell Subsets Differs in Gut and Blood of HIV-Positive Patients on ART: Implications for Viral Persistence.
- Human leukocyte antigen B*57 does not fully explain hepatitis C clearance in HIV controllers.
- Temporal Trends in Presentation and Survival for HIV-Associated Lymphoma in the Antiretroviral Therapy Era.
- Immune activation and HIV persistence: implications for curative approaches to HIV infection.
- Association of HLA-DRB1-restricted CD4(+) T cell responses with HIV immune control.
- AIDS alters the commensal plasma virome.
- Dysbiosis of the Gut Microbiota Is Associated with HIV Disease Progression and Tryptophan Catabolism.
- Cell-based measures of viral persistence are associated with immune activation and programmed cell death protein 1 (PD-1)-expressing CD4+ T cells.
- Association Study of Common Genetic Variants and HIV-1 Acquisition in 6,300 Infected Cases and 7,200 Controls.
- Association of early HIV viremia with mortality after HIV-associated lymphoma.
- Challenges in Detecting HIV Persistence during Potentially Curative Interventions: A Study of the Berlin Patient.
- Influence of HLA-C expression level on HIV control.
- The immunologic effects of maraviroc intensification in treated HIV-infected individuals with incomplete CD4+ T cell recovery: a randomized trial.
- Elevated levels of asymmetric dimethylarginine are associated with lower CD4+ count and higher viral load in HIV-infected individuals.
- Mortality in well controlled HIV in the continuous antiretroviral therapy arms of the SMART and ESPRIT trials compared with the general population.
- Preclinical Evaluation of HIV Eradication Strategies in the Simian Immunodeficiency Virus-Infected Rhesus Macaque: A Pilot Study Testing Inhibition of Indoleamine 2,3-...
- Immunosenescence is associated with presence of Kaposi's sarcoma in antiretroviral treated human immunodeficiency virus infection.
- Predictive Accuracy of the Veterans Aging Cohort Study Index for Mortality With HIV Infection: A North American Cross Cohort Analysis.
- Roadblocks to translational challenges on viral pathogenesis.
- Pegylated Interferon alfa-2a monotherapy results in suppression of HIV type 1 replication and decreased cell-associated HIV DNA integration.
- Differential expression of CD96 surface molecule represents CD8? T cells with dissimilar effector function during HIV-1 infection.
- Lack of Evidence for mtDNA as a Biomarker of Innate Immune Activation in HIV Infection.
- HIV(+) Viremic Slow Progressors Maintain Low Regulatory T Cell Numbers in Rectal Mucosa but Exhibit High T Cell Activation.
- The Effect of a "Universal Antiretroviral Therapy" Recommendation on HIV RNA Levels among HIV-Infected Patients Entering Care with a CD4 Count Greater than 500/μl in ...
- HIV infection, lymphoid fibrosis, and disease.
- A Randomized, Controlled Trial Assessing the Effects of Raltegravir Intensification on Endothelial Function in Treated HIV Infection.
- The Activity of the Integrase Inhibitor Dolutegravir Against HIV-1 Variants Isolated From Raltegravir-Treated Adults.
- Impact of protective KIR/HLA genotypes on NK Cell and T cell function in HIV-1 infected controllers.
- Lenalidomide enhancement of human T cell functions in human immunodeficiency virus (HIV)-infected and HIV-negative CD4 T lymphocytopenic patients.
- Towards an HIV cure: a global scientific strategy.
- Public health: Towards a cure for HIV.
- Doppler echocardiography does not accurately estimate pulmonary artery systolic pressure in HIV-infected patients.
- Influence of HAART on Alternative Reading Frame Immune Responses over the Course of HIV-1 Infection.
- Immunosenescence and HIV.
- Immunologic basis of cardiovascular disease in HIV-infected adults.
- Blood T-cell receptor diversity decreases during the course of HIV infection, but the potential for a diverse repertoire persists.
- Carotid Intima-Media Thickness Progression in HIV-Infected Adults Occurs Preferentially at the Carotid Bifurcation and Is Predicted by Inflammation.
- Plasma HIV-1 RNA Levels During Antiretroviral Therapy: How Low Is Low Enough?
- Epistatic interactions between Fc (GM) and Fc?R genes and the host control of human immunodeficiency virus replication.
- Carotid intima-media thickness among human immunodeficiency virus-infected patients without coronary calcium.
- Expansion of CD8+ T cells lacking Sema4D/CD100 during HIV-1 infection identifies a subset of T cells with decreased functional capacity.
- The Effect of AIDS Clinical Trials Group Protocol 5164 on the Time From Pneumocystis jirovecii Pneumonia Diagnosis to Antiretroviral Initiation in Routine Clinical Pra...
- Immune Activation in the Pathogenesis of Treated Chronic HIV Disease: A Workshop Summary.
- Increased Frequency of Regulatory T-Cells Accompanies Increased T-Cell Immune Activation in Rectal Mucosa of HIV+ Non-Controllers.
- Impact of CD8+ T Cell Activation on CD4+ T Cell Recovery and Mortality in HIV-infected Ugandans Initiating Antiretroviral Therapy.
- Drug Effectiveness Explained: The Mathematics of Antiviral Agents for HIV.
- Host response to translocated microbial products predicts outcomes of patients with HBV or HCV infection.
- Breaking free of sample size dogma to perform innovative translational research.
- Valganciclovir reduces T cell activation in HIV-infected individuals with incomplete CD4+ T cell recovery on antiretroviral therapy.
- HIV disease progression despite suppression of viral replication is associated with exhaustion of lymphopoiesis.
- Strong human endogenous retrovirus (HERV)-specific T cell responses are associated with control of HIV-1 in chronic infection.
- Modification of the Abbott RealTime assay for detection of HIV-1 plasma RNA viral loads less than one copy per milliliter.
- Cardiovascular risks associated with abacavir and tenofovir exposure in HIV-infected persons.
- Differential persistence of transmitted HIV-1 drug resistance mutation classes.
- Increased HIV-specific CD8+ T-cell cytotoxic potential in HIV elite controllers is associated with T-bet expression.
- Association of vitamin D insufficiency with carotid intima-media thickness in HIV-infected persons.
- Reappraisal of the relationship between the HIV-1-protective single-nucleotide polymorphism 35 kilobases upstream of the HLA-C gene and surface HLA-C expression.
- A randomized, controlled trial of raltegravir intensification in antiretroviral-treated, HIV-infected patients with a suboptimal CD4+ T cell response.
- Old age and anti-CMV immunity are associated with altered T cell reconstitution in HIV-1 infected patients.
Schools
University of California At San Francisco
Doctors Specialties
- Internal Medicine
Accepted Insurances
Awards
- Elected Member
Education
-
UCSF -
University of California San Francisco School of Medicine
Hospital
-
UCSF Medical Center
Helpful Reviews
Similar Doctors
|
|
Dr. Todd A. Levine, MD |
|
|
Dr. Joseph Leung, MD |
|
Dr. Harlan B. Watkins, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Thinn T. Khaing, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christopher P. Moriates, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael J. Martin, MD |
|
|
Dr. Courtney B. Sherman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Felicia L. Sterman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Merik S. Gross, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Justin Liu, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Lawrence Bryson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Katherine C. Thomas, MD |
|
|
Dr. Jerome N. Jew, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Timothy C. Poore, MD |
|
|
Dr. Cleon H. Yee, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kerstin Morehead, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ira D. Goldfine, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Jinwoo M. Kim, MD
This Doctor is OpenDoctor Recommended.
|